MONDANELLI, GIADA
 Distribuzione geografica
Continente #
NA - Nord America 1.203
EU - Europa 1.142
AS - Asia 462
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 1
Totale 2.816
Nazione #
US - Stati Uniti d'America 1.203
IT - Italia 471
IE - Irlanda 213
RO - Romania 202
VN - Vietnam 152
HK - Hong Kong 136
SG - Singapore 88
CN - Cina 64
FR - Francia 61
DE - Germania 36
CZ - Repubblica Ceca 27
BE - Belgio 26
RU - Federazione Russa 25
SE - Svezia 23
FI - Finlandia 21
UA - Ucraina 15
TR - Turchia 11
CH - Svizzera 7
KR - Corea 6
CI - Costa d'Avorio 5
GB - Regno Unito 5
GR - Grecia 4
EU - Europa 3
PL - Polonia 3
UZ - Uzbekistan 3
NL - Olanda 2
AT - Austria 1
BR - Brasile 1
JP - Giappone 1
LB - Libano 1
Totale 2.816
Città #
Perugia 296
Chandler 275
Dublin 213
Bucharest 202
Dong Ket 152
Hong Kong 136
Redmond 130
San Mateo 91
Singapore 66
Altamura 58
Medford 48
Princeton 45
Lawrence 43
Wilmington 36
Beijing 30
Boardman 30
Des Moines 30
Andover 26
Brussels 26
Pisa 26
Ann Arbor 22
Falls Church 22
Brno 17
Los Angeles 16
Redwood City 15
Norwalk 12
Izmir 11
Dearborn 10
Olomouc 10
Helsinki 9
Saint Petersburg 9
Fremont 7
Ashburn 6
San Diego 6
Woodbridge 6
Abidjan 5
Chicago 5
Munich 5
New York 5
Rome 5
Seoul 5
Hanover 4
Menlo Park 4
San Paolo di Civitate 4
Assisi 3
Civitanova Marche 3
Esslingen am Neckar 3
Houston 3
L’Aquila 3
Nanjing 3
Nichelino 3
Paris 3
Boydton 2
Fairfield 2
Florence 2
Lappeenranta 2
Macerata 2
Milan 2
Monreale 2
Nagold 2
Nuremberg 2
Saint Louis 2
Spoleto 2
West Jordan 2
Amsterdam 1
Bologna 1
Campo Grande 1
Castel Maggiore 1
Castiglione del Lago 1
Chengdu 1
Clarksville 1
Collazzone 1
Corciano 1
Den Haag 1
Düsseldorf 1
Falkenstein 1
Frankfurt Am Main 1
Freiburg 1
Grossmuehlingen 1
Guangzhou 1
Gunzenhausen 1
Kraków 1
Lugano 1
Mainz 1
Marseille 1
Mont-saint-aignan 1
Nottingham 1
Rimini 1
San Pietro In Casale 1
Santarcangelo di Romagna 1
Seattle 1
Shanghai 1
Shenzhen 1
Southend 1
Terni 1
Vienna 1
Wuhan 1
Totale 2.260
Nome #
Assessment of TILs, IDO-1, and PD-L1 in resected non-small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications 139
Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells 134
Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1. 125
A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells 118
Class IA PI3Ks regulate subcellular and functional dynamics of IDO1 117
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 112
Amino-acid sensing and degrading pathways in immune regulation 109
IL‐35Ig–expressing dendritic cells induce tolerance via Arginase 1 101
Identification of a 2-propanol analogue modulating the non-enzymatic function of indoleamine 2,3-dioxygenase 1 100
Amino acid metabolism as drug target in autoimmune diseases 100
Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes 87
LPS-conditioned dendritic cells confer endotoxin tolerance contingent on tryptophan catabolism 85
Immunoregulatory interplay between arginine and tryptophan metabolism in health and disease 81
Aryl hydrocarbon Receptor and RelB control long term expression of Indoleamine 2,3-dioxygenase-1 in endotoxin tolerance 80
Artocarpus tonkinensis extract inhibits LPS-triggered inflammation markers and suppresses RANKL-induced osteoclastogenesis in RAW264.7 77
Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1 in juvenile diabetes 76
Antigen-specific immunoregulation by IL-35Ig-transfected dendritic cells 67
Islet antigen-pulsed dendritic cells expressing ectopic IL-35Ig protect nonobese diabetic mice from autoimmune diabetes. 62
Ectopic expression of IL-35Ig by dendritic cells induces tolerance via Arginase 1. 61
A novel mutation of indoleamine 2,3-dioxygenase 1 causes a rapid proteasomal degradation and compromises protein function 58
Indoleamine 2,3-dioxygenase 2 immunohistochemical expression in a resected non-small cell lung cancer series 55
Reinstalling immune regulatory tryptophan catabolism in juvenile diabetes via interleukin 6 receptor blockade 54
The immune regulation in cancer by the amino acid metabolizing enzymes ARG and IDO 52
3-hydroxy-L-kynurenamine is an immunomodulatory biogenic amine 52
Induction of immunosuppressive functions and NF-kappa B by FLIP in monocytes 50
Pharmacologic Induction of Endotoxin Tolerance in Dendritic Cells by L-Kynurenine 49
Novel mutations in the WFS1 gene are associated with Wolfram syndrome and systemic inflammation 49
Effects of probiotic administration on immune responses of children and adolescents with type 1 diabetes to a quadrivalent inactivated influenza vaccine 48
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation 47
Indoleamine 2,3-Dioxygenase 2 Immunohistochemical Expression in Resected Human Non-small Cell Lung Cancer: A Potential New Prognostic Tool 46
Challenges in the design of reliable immuno-oncology mouse models to inform drug development 44
Loss of IDO1 Expression From Human Pancreatic -Cells Precedes Their Destruction During the Development of Type 1 Diabetes 44
Wolfram syndrome, a rare neurodegenerative disease: From pathogenesis to future treatment perspectives 42
Reply to Han et al.: On track for an IDO1-based personalized therapy in autoimmunity 40
Effect of Probiotic Administration on Serum Tryptophan Metabolites in Pediatric Type 1 Diabetes Patients 40
The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes. 38
Differentiation of Myeloid-derived Suppressor Cells from Murine Bone Marrow and Their Co-culture with Splenic Dendritic Cells 36
Polyamines and Kynurenines at the Intersection of Immune Modulation 35
The landscape of AhR regulators and coregulators to fine-tune AhR functions 35
Immune Checkpoint Molecules, Personalized Immunotherapy, and Autoimmune Diabetes 33
In-depth characterization of phenolic profiling of Moraiolo extra-virgin olive oil extract and initial investigation of the inhibitory effect on Indoleamine-2,3-Dioxygenase (IDO1) enzyme 33
A back-door insight into the modulation of Src kinase activity by the polyamine spermidine 30
Pathogenetic Interplay Between IL-6 and Tryptophan Metabolism in an Experimental Model of Obesity 30
Opportunities and challenges in drug discovery targeting metabotropic glutamate receptor 4 28
The signaling function of IDO1 incites the malignant progression of mouse B16 melanoma 26
Current Challenges for IDO2 as Target in Cancer Immunotherapy 24
SLC6A4 DNA Methylation Levels and Serum Kynurenine/Tryptophan Ratio in Eating Disorders: A Possible Link with Psychopathological Traits? 20
Decoding the Complex Crossroad of Tryptophan Metabolic Pathways 20
The catalytic inhibitor epacadostat can affect the non-enzymatic function of IDO1 14
Membrane Localization and Phosphorylation of Indoleamine 2,3-Dioxygenase 2 (IDO2) in A549 Human Lung Adenocarcinoma Cells: First Steps in Exploring Its Signaling Function 13
Modulation of Indoleamine 2,3-Dioxygenase 1 During Inflammatory Bowel Disease Activity in Humans and Mice 11
Epacadostat stabilizes the apo-form of IDO1 and signals a pro-tumorigenic pathway in human ovarian cancer cells 10
Unrevealing the Role of TLRs in the Pathogenesis of Autoimmune Disease by Using Mouse Model of Diabetes 9
The double life of serotonin metabolites: in the mood for joining neuronal and immune systems 8
Assessment of TILs, IDO-1 and PD-L1 in resected non small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications. 7
Chromatographic measurement of 3-hydroxyanthranilate 3,4-dioxygenase activity reveals that edaravone can mitigate the formation of quinolinic acid through a direct enzyme inhibition 7
Totale 3.068
Categoria #
all - tutte 11.545
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.545


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020214 7 7 19 2 7 16 3 13 60 34 16 30
2020/2021460 1 10 2 9 138 14 54 13 39 17 6 157
2021/2022816 1 71 8 6 28 14 4 115 152 148 76 193
2022/2023901 47 177 19 67 93 96 1 43 300 12 33 13
2023/2024482 33 58 14 8 6 6 126 7 29 20 63 112
2024/202516 16 0 0 0 0 0 0 0 0 0 0 0
Totale 3.068